Two Day Seminar: Exploring Data Integrity To Include FDA, WHO and EMA's Latest Guidance for Industry (2015/2016) - Cambridge, United States - May 18-19, 2017 - Research and Markets

DUBLIN, Mar. 3, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Exploring Data Integrity To Include FDA, WHO and EMA's Latest Guidance for Industry (2015/2016)" conference to their offering.

Several documents have recently been published by the FDA, MHRA and WHO. The FDA Guidance for Industry, "Data Integrity and Compliance with CGMP" was published as a DRAFT guidance in April 2016.

This Guidance was issued to clarify the role of Data Integrity in CGMP for drugs. In March 2015, the MHRA published a Guidance entitled "MHRA GMP Data Integrity Definitions and Guidance for Industry" which mirrored the 2016 FDA document.

Various source documents to include 21 CFR 210/211, FDA Guidances for Industry, Standard Industry Practices and other International sources will be used to support the conclusions developed by each team during this two day seminar.

The objective of this two day seminar is to explore and define the necessary elements in the development and implementation of a Data Integrity program and how to maintain Quality Systems that minimize these issues. This seminar is designed to assist in assuring that your organization is maintaining itself within cGMP compliance.

Case studies to include Warning Letters will be discussed to illustrate the wide array of issues that continue to arise and how to find them within your organization and your vendors before the regulators find them for you. This seminar represents a great opportunity for a team from your Corporation to attend and mutually benefit each other.

Learning Objectives:

- Assure your understanding of the fundamental causes of Data Integrity issues
- Be able to identify these key elements
- Understand how cGMP regulations impact Data Integrity issues
- Understanding the various inspection approaches to monitor for Data Integrity
- Learn how to determine the regulatory requirements required to assure Data Integrity
- Understand the consequences of questionable data and how they may lead to seizures, import alerts, etc

Who Should Attend:

- Quality professionals
- Regulatory professionals
- Compliance professionals
- Manufacturing engineers
- Quality engineers
- Quality auditors
- Quality Control
- Microbiology
- Document control specialists

For more information about this conference visit http://www.researchandmarkets.com/research/5s6j9b/exploring_data

Media Contact:

Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]